Astrazeneca Pharma India
Sebi censures Astrazeneca promoter, Elliot Group for unfair trade practices
Sebi said that the entire procedure was intended to dilute the reverse book building mechanism for discovery of delisting price of the scrip as per stipulations
 "Sebi censures Astrazeneca promoter, Elliot Group for unfair trade practices")
Updated On : 07 Jun 2020 | 1:31 PM IST
Diabetes will be one of our key focus areas: AstraZeneca's Gagan Singh Bedi
British drugmaker AstraZeneca, which has committed to invest $90 million in India over five years, has set up Integrated Cardio Metabolic Centre in Kerala for holistic treatment of diabetes
 "Diabetes will be one of our key focus areas: AstraZeneca's Gagan Singh Bedi")
Updated On : 01 Mar 2020 | 9:19 PM IST
AstraZeneca gains 5% on marketing nod to launch cancer drug in India
The stock was up 5% to Rs 1,416 after the company said it has received approval from the Drug Controller General of India to market Durvalumab, a cancer treatment medicine.
 "AstraZeneca gains 5% on marketing nod to launch cancer drug in India")
Updated On : 22 Jun 2018 | 10:05 AM IST
